Table III.
Laboratory parameters, haemodynamics and sedation-related parameters of patients in both groups
| Parameter | Contact force (n = 31) |
Standard mapping (n = 112) |
Value of p |
|---|---|---|---|
| Baseline systolic blood pressure, mean ± SD [mm Hg] | 128.1 ±20.1 | 122.2 ±18 | 0.18 |
| Baseline diastolic blood pressure, mean ± SD [mm Hg] | 71.6 ±14.2 | 74.8 ±11.3 | 0.25 |
| Post-procedure systolic blood pressure, mean ± SD [mm Hg] | 108.1 ±19.6 | 104.5 ±14.1 | 0.44 |
| Post-procedure diastolic blood pressure, mean ± SD [mm Hg] | 68.8 ±15 | 69.1 ±9.3 | 0.95 |
| Baseline SaO2, mean ± SD (%) | 97.6 ±2.2 | 97 ±2.1 | 0.2 |
| Post-procedure SaO2, mean ± SD (%) | 97.1 ±2.3 | 96.1 ±2.7 | 0.12 |
| Haemoglobin, mean ± SD [g/dl] | 13.1 ±2 | 14.1 ±2.5 | 0.14 |
| Glucose, mean ± SD [mg/dl] | 114.2 ±22.9 | 111.5 ±19.9 | 0.59 |
| Baseline CRP, mean ± SD [mg/l] | 12.9 ±16.1 | 17.8 ±26.3 | 0.43 |
| Baseline AST, mean ± SD [U/l] | 37.4 ±27 | 32.3 ±17 | 0.53 |
| Baseline TSH, mean ± SD [mU/l] | 1.4 ±1.3 | 1.6 ±1 | 0.62 |
| Total midazolam dose, mean ± SD [mg] | 6.1 ±2 | 6.4 ±2.8 | 0.69 |
| Total propofol dose, mean ± SD [mg] | 937.8 ±396.3 | 954.9 ±377.5 | 0.87 |
AST – aspartate aminotransferase, CRP – C-reactive protein, SaO2 – arterial oxygen saturation, TSH – thyroid-stimulating hormone;
*
Statistically significant